BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22151250)

  • 1. Canine corneal fibroblast and myofibroblast transduction with AAV5.
    Bosiack AP; Giuliano EA; Gupta R; Mohan RR
    Vet Ophthalmol; 2012 Sep; 15(5):291-8. PubMed ID: 22151250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of suberoylanilide hydroxamic acid (Vorinostat) in the treatment of canine corneal fibrosis.
    Bosiack AP; Giuliano EA; Gupta R; Mohan RR
    Vet Ophthalmol; 2012 Sep; 15(5):307-14. PubMed ID: 22212187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene delivery in the equine cornea: a novel therapeutic strategy.
    Buss DG; Giuliano E; Sharma A; Mohan RR
    Vet Ophthalmol; 2010 Sep; 13(5):301-6. PubMed ID: 20840107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decorin-PEI nanoconstruct attenuates equine corneal fibroblast differentiation.
    Donnelly KS; Giuliano EA; Sharma A; Tandon A; Rodier JT; Mohan RR
    Vet Ophthalmol; 2014 May; 17(3):162-9. PubMed ID: 23718145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors.
    Glushakova LG; Timmers AM; Pang J; Teusner JT; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3505-13. PubMed ID: 16877422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor reversal of the corneal myofibroblast phenotype.
    Maltseva O; Folger P; Zekaria D; Petridou S; Masur SK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2490-5. PubMed ID: 11581188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts.
    Kurosaka H; Kurosaka D; Kato K; Mashima Y; Tanaka Y
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):699-704. PubMed ID: 9538875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of Pirfenidone for treating equine corneal scarring.
    Fink MK; Giuliano EA; Tandon A; Mohan RR
    Vet Ophthalmol; 2015 May; 18(3):242-50. PubMed ID: 25041235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.
    Mohan RR; Sinha S; Tandon A; Gupta R; Tovey JC; Sharma A
    PLoS One; 2011 Apr; 6(4):e18771. PubMed ID: 21533273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation.
    Folger PA; Zekaria D; Grotendorst G; Masur SK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2534-41. PubMed ID: 11581194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer.
    Sharma A; Rodier JT; Tandon A; Klibanov AM; Mohan RR
    Mol Vis; 2012; 18():2598-607. PubMed ID: 23112572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy.
    Liu J; Saghizadeh M; Tuli SS; Kramerov AA; Lewin AS; Bloom DC; Hauswirth WW; Castro MG; Schultz GS; Ljubimov AV
    Mol Vis; 2008; 14():2087-96. PubMed ID: 19023450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C: a promising agent for the treatment of canine corneal scarring.
    Gupta R; Yarnall BW; Giuliano EA; Kanwar JR; Buss DG; Mohan RR
    Vet Ophthalmol; 2011 Sep; 14(5):304-12. PubMed ID: 21929607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.
    Mohan RR; Tandon A; Sharma A; Cowden JW; Tovey JC
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4833-41. PubMed ID: 21551414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes.
    Jester JV; Barry-Lane PA; Cavanagh HD; Petroll WM
    Cornea; 1996 Sep; 15(5):505-16. PubMed ID: 8862928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition.
    Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D
    J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detectable reporter gene expression following transduction of adenovirus and adeno-associated virus serotype 2 vectors within full-thickness osteoarthritic and unaffected canine cartilage in vitro and unaffected guinea pig cartilage in vivo.
    Santangelo KS; Baker SA; Nuovo G; Dyce J; Bartlett JS; Bertone AL
    J Orthop Res; 2010 Feb; 28(2):149-55. PubMed ID: 19658157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro adenovirus mediated gene transfer to the human cornea.
    Jessup CF; Brereton HM; Coster DJ; Williams KA
    Br J Ophthalmol; 2005 Jun; 89(6):658-61. PubMed ID: 15923495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of replication in human corneal endothelial cells by E2F2 transcription factor cDNA transfer.
    McAlister JC; Joyce NC; Harris DL; Ali RR; Larkin DF
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3597-603. PubMed ID: 16186339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes.
    Pei Y; Reins RY; McDermott AM
    Exp Eye Res; 2006 Nov; 83(5):1063-73. PubMed ID: 16822507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.